ATE110963T1 - Mittel zur hemmung der alpha-amylase aktivität. - Google Patents

Mittel zur hemmung der alpha-amylase aktivität.

Info

Publication number: ATE110963T1
Authority: AT; Austria
Prior art keywords: tea; agents; theaflavin; amylase activity; inhibiting alpha
Prior art date: 1989-10-19

Application number

AT90107475T

Other languages

English (en)

Inventor

Yukihiko Hara

Miwa Honda

Original Assignee

Mitsui Norin Kk

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-10-19

Filing date

1990-04-19

Publication date

1994-09-15

1990-04-19 Application filed by Mitsui Norin Kk filed Critical Mitsui Norin Kk

1994-09-15 Application granted granted Critical

1994-09-15 Publication of ATE110963T1 publication Critical patent/ATE110963T1/de

Links

244000269722 Thea sinensis Species 0.000 abstract 4
235000013616 tea Nutrition 0.000 abstract 3
XMOCLSLCDHWDHP-IUODEOHRSA-N epi-Gallocatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-IUODEOHRSA-N 0.000 abstract 2
229930013915 (+)-catechin Natural products 0.000 abstract 1
235000007219 (+)-catechin Nutrition 0.000 abstract 1
PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 abstract 1
PFTAWBLQPZVEMU-ZFWWWQNUSA-N (+)-epicatechin Natural products C1([C@@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-ZFWWWQNUSA-N 0.000 abstract 1
WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 abstract 1
PFTAWBLQPZVEMU-UKRRQHHQSA-N (-)-epicatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-UKRRQHHQSA-N 0.000 abstract 1
LSHVYAFMTMFKBA-TZIWHRDSSA-N (-)-epicatechin-3-O-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=CC=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 LSHVYAFMTMFKBA-TZIWHRDSSA-N 0.000 abstract 1
LSHVYAFMTMFKBA-UHFFFAOYSA-N ECG Natural products C=1C=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 LSHVYAFMTMFKBA-UHFFFAOYSA-N 0.000 abstract 1
WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 abstract 1
IPMYMEWFZKHGAX-UHFFFAOYSA-N Isotheaflavin Natural products OC1CC2=C(O)C=C(O)C=C2OC1C(C1=C2)=CC(O)=C(O)C1=C(O)C(=O)C=C2C1C(O)CC2=C(O)C=C(O)C=C2O1 IPMYMEWFZKHGAX-UHFFFAOYSA-N 0.000 abstract 1
XMOCLSLCDHWDHP-UHFFFAOYSA-N L-Epigallocatechin Natural products OC1CC2=C(O)C=C(O)C=C2OC1C1=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-UHFFFAOYSA-N 0.000 abstract 1
235000006468 Thea sinensis Nutrition 0.000 abstract 1
UXRMWRBWCAGDQB-UHFFFAOYSA-N Theaflavin Natural products C1=CC(C2C(CC3=C(O)C=C(O)C=C3O2)O)=C(O)C(=O)C2=C1C(C1OC3=CC(O)=CC(O)=C3CC1O)=CC(O)=C2O UXRMWRBWCAGDQB-UHFFFAOYSA-N 0.000 abstract 1
241000700605 Viruses Species 0.000 abstract 1
KMJPKUVSXFVQGZ-WQLSNUALSA-N [(2r,3r)-5,7-dihydroxy-2-[3,4,5-trihydroxy-6-oxo-1-[(2r,3r)-3,5,7-trihydroxy-3,4-dihydro-2h-chromen-2-yl]benzo[7]annulen-8-yl]-3,4-dihydro-2h-chromen-3-yl] 3,4,5-trihydroxybenzoate Chemical class O([C@@H]1CC2=C(O)C=C(O)C=C2O[C@@H]1C1=CC(=O)C(O)=C2C(O)=C(O)C=C(C2=C1)[C@H]1OC2=CC(O)=CC(O)=C2C[C@H]1O)C(=O)C1=CC(O)=C(O)C(O)=C1 KMJPKUVSXFVQGZ-WQLSNUALSA-N 0.000 abstract 1
102000004139 alpha-Amylases Human genes 0.000 abstract 1
108090000637 alpha-Amylases Proteins 0.000 abstract 1
229940024171 alpha-amylase Drugs 0.000 abstract 1
235000020279 black tea Nutrition 0.000 abstract 1
239000003795 chemical substances by application Substances 0.000 abstract 1
239000000470 constituent Substances 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
LPTRNLNOHUVQMS-UHFFFAOYSA-N epicatechin Natural products Cc1cc(O)cc2OC(C(O)Cc12)c1ccc(O)c(O)c1 LPTRNLNOHUVQMS-UHFFFAOYSA-N 0.000 abstract 1
235000012734 epicatechin Nutrition 0.000 abstract 1
DZYNKLUGCOSVKS-UHFFFAOYSA-N epigallocatechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3cc(O)c(O)c(O)c3 DZYNKLUGCOSVKS-UHFFFAOYSA-N 0.000 abstract 1
229940030275 epigallocatechin gallate Drugs 0.000 abstract 1
239000004615 ingredient Substances 0.000 abstract 1
230000002401 inhibitory effect Effects 0.000 abstract 1
150000008442 polyphenolic compounds Chemical class 0.000 abstract 1
235000013824 polyphenols Nutrition 0.000 abstract 1
235000014620 theaflavin Nutrition 0.000 abstract 1
IPMYMEWFZKHGAX-ZKSIBHASSA-N theaflavin Chemical compound C1=C2C([C@H]3OC4=CC(O)=CC(O)=C4C[C@H]3O)=CC(O)=C(O)C2=C(O)C(=O)C=C1[C@@H]1[C@H](O)CC2=C(O)C=C(O)C=C2O1 IPMYMEWFZKHGAX-ZKSIBHASSA-N 0.000 abstract 1
229940026509 theaflavin Drugs 0.000 abstract 1
FJYGFTHLNNSVPY-BBXLVSEPSA-N theaflavin digallate Chemical compound C1=C([C@@H]2[C@@H](CC3=C(O)C=C(O)C=C3O2)O)C=C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(=O)C2=C1C([C@H]1OC3=CC(O)=CC(O)=C3C[C@H]1O)=CC(O)=C2OC(=O)C1=CC(O)=C(O)C(O)=C1 FJYGFTHLNNSVPY-BBXLVSEPSA-N 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/16—Tea extraction; Tea extracts; Treating tea extract; Making instant tea
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Natural Medicines & Medicinal Plants (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Medical Informatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Mycology (AREA)
Microbiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Alternative & Traditional Medicine (AREA)
Biotechnology (AREA)
Botany (AREA)
Polymers & Plastics (AREA)
Food Science & Technology (AREA)
Diabetes (AREA)
Hematology (AREA)
Child & Adolescent Psychology (AREA)
Obesity (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Plant Substances (AREA)
Pyrane Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Compounds Of Unknown Constitution (AREA)
Tea And Coffee (AREA)
Fats And Perfumes (AREA)

AT90107475T 1989-10-19 1990-04-19 Mittel zur hemmung der alpha-amylase aktivität. ATE110963T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP1270228A JP3018013B2 (ja)	1989-10-19	1989-10-19	α―アミラーゼ活性阻害剤

Publications (1)

Publication Number	Publication Date
ATE110963T1 true ATE110963T1 (de)	1994-09-15

Family

ID=17483335

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT90107475T ATE110963T1 (de)	1989-10-19	1990-04-19	Mittel zur hemmung der alpha-amylase aktivität.

Country Status (7)

Country	Link
EP (1)	EP0423419B1 (de)
JP (1)	JP3018013B2 (de)
KR (1)	KR0178522B1 (de)
AT (1)	ATE110963T1 (de)
AU (1)	AU628514B2 (de)
CA (1)	CA2014971C (de)
DE (1)	DE69012268T2 (de)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2727471B2 (ja) *	1989-09-14	1998-03-11	三井農林株式会社	インフルエンザウィルス感染予防剤
JPH04253918A (ja) *	1991-02-05	1992-09-09	Mitsui Norin Kk	血糖上昇抑制剤
FR2788438B1 (fr) *	1999-01-14	2003-10-03	Arkopharma Laboratoires	Composition pour le traitement de l'obesite et procede de traitement esthetique
JP5354833B2 (ja) *	2000-03-10	2013-11-27	株式会社ヤクルト本社	α−アミラーゼ活性阻害剤
JP2011105763A (ja) *	2000-06-21	2011-06-02	Kao Corp	Ｐｐａｒ依存的遺伝子転写活性化剤
WO2002009734A1 (en) *	2000-08-01	2002-02-07	Oryza Oil & Fat Chemical Co.,Ltd.	Sugar absorption inhibitors and process for producing the same
JP4727790B2 (ja) *	2000-08-02	2011-07-20	グンゼ株式会社	抗肥満剤
ES2236331T3 (es)	2000-11-17	2005-07-16	Kao Corporation	Bebidas envasadas.
WO2003024468A1 (en) *	2001-09-19	2003-03-27	Bioneer Corporation	Substances extracted from corn which can inhibit the activities of amylase, pharmaceutical compositions and food additives containing the same extracts for treatment or prevention of obesity and diabetes mellitus, and processes for their preparations
JP3403400B1 (ja)	2001-09-28	2003-05-06	花王株式会社	容器詰飲料
JP3378577B1 (ja)	2001-09-28	2003-02-17	花王株式会社	飲料
US7157493B2 (en)	2001-11-28	2007-01-02	Nashai Biotech, Llc	Methods of making and using theaflavin, theaflavin-3-gallate, theaflavin-3′-gallate and theaflavin 3,3′-digallate and mixtures thereof
NZ533190A (en) *	2001-11-28	2008-07-31	Nashai Biotech Llc	Methods of making and using theaflavin, theaflavin-3-gallate, theaflavin-3'-gallate and theaflavin 3,3'-digallate and mixtures thereof
FR2836336B1 (fr) *	2002-02-26	2004-08-27	Diana Ingredients	Utilisation dans un traitement cosmetique d'une fraction phenolique riche en dihydrochalcones
FR2836337B1 (fr) *	2002-02-28	2004-11-19	Bio Serae Laboratoires	Utilisation des polymeres procyanidoliques a titre d'agents inhibuteurs des alpha-amylases et application dans des compositions a visees dietetiques
EP1557097B1 (de)	2002-10-28	2013-10-23	Kao Corporation	Verfahren zur entfernung von koffein aus einer koffeinhaltigen katechinverbindungszusammensetzung
US20060165671A1 (en) *	2002-11-07	2006-07-27	Daniel Raederstorff	Novel nutraceutical compositions comprising epigallocatechin gallate
JP4776149B2 (ja) *	2003-03-28	2011-09-21	クラシエフーズ株式会社	糖質吸収抑制剤および食品
US7220444B2 (en)	2003-09-26	2007-05-22	Kao Corporation	Packaged beverages
JP3597857B2 (ja)	2003-10-31	2004-12-08	花王株式会社	容器詰茶飲料
EP1690457B1 (de)	2003-12-02	2010-08-11	Kao Corporation	Verpacktes getränk
JP3766670B2 (ja)	2003-12-16	2006-04-12	花王株式会社	容器詰飲料
ES2367889T3 (es)	2003-12-18	2011-11-10	Kao Corporation	Bebida embotellada.
JP3597859B2 (ja)	2003-12-22	2004-12-08	花王株式会社	容器詰緑茶飲料及びその製造法
JP2006016367A (ja) *	2004-07-05	2006-01-19	Suntory Ltd	リパーゼ阻害剤
JP3742096B1 (ja) *	2005-02-08	2006-02-01	花王株式会社	非茶系容器詰飲料
JP3742094B1 (ja) *	2004-11-04	2006-02-01	花王株式会社	非茶系容器詰飲料
KR20070026005A (ko) *	2005-09-01	2007-03-08	카오카부시키가이샤	정제 녹차 추출물의 제조 방법
JP4884003B2 (ja)	2005-12-27	2012-02-22	花王株式会社	容器詰烏龍茶飲料
WO2007099715A1 (ja)	2006-03-02	2007-09-07	Kao Corporation	精製茶抽出物の製造方法
JP4569965B2 (ja)	2006-04-17	2010-10-27	花王株式会社	精製緑茶抽出物の製造法
JP4562682B2 (ja)	2006-04-17	2010-10-13	花王株式会社	精製緑茶抽出物の製造法
JP5080835B2 (ja)	2006-07-04	2012-11-21	花王株式会社	発泡性容器詰飲料
JP2008088146A (ja)	2006-09-08	2008-04-17	Kao Corp	インスリン感受性改善剤
EP2098121B1 (de)	2006-12-22	2013-09-18	Kao Corporation	Containerverpacktes grünteegetränk
EP2095718B1 (de)	2006-12-28	2013-04-17	Kao Corporation	Teeextrakt
JP2008200032A (ja)	2007-01-24	2008-09-04	Kao Corp	パン類
WO2008090740A1 (ja)	2007-01-24	2008-07-31	Kao Corporation	菓子類
KR101463639B1 (ko)	2007-05-08	2014-12-04	카오카부시키가이샤	환원 음료용 농축 조성물
JP5517412B2 (ja)	2007-05-24	2014-06-11	花王株式会社	精製緑茶抽出物
KR101475758B1 (ko)	2007-08-08	2014-12-23	가오 가부시키가이샤	차 추출물의 제조방법
US20100209585A1 (en)	2007-08-30	2010-08-19	Kao Corporation	Instant powder drink
KR20100055448A (ko)	2007-09-05	2010-05-26	가오 가부시키가이샤	정제 차추출물의 제조방법
JP2009268420A (ja) *	2008-05-09	2009-11-19	Kataoka & Co Ltd	機能性食品組成物
JP2010222277A (ja) *	2009-03-23	2010-10-07	Kao Corp	食後の血糖値上昇抑制剤
JP2011182703A (ja) *	2010-03-08	2011-09-22	Asahi Group Holdings Ltd	１，２−ジ−Ｏ−ガロイル−４，６−ＨＨＤＰ−ｂ−ｄ−グルコピラノースを高濃度で含有する飲食品
JP5744507B2 (ja) *	2010-12-24	2015-07-08	三井農林株式会社	α−アミラーゼ阻害剤
US20170182110A1 (en) *	2014-04-23	2017-06-29	Nippon Paper Industries Co., Ltd.	Agent for preventing or ameliorating diabetes
JP6355129B2 (ja) *	2014-11-06	2018-07-11	国立研究開発法人農業・食品産業技術総合研究機構	１，２−ジ−Ｏ−ガロイル−４，６−ＨＨＤＰ−ｂ−ｄ−グルコピラノースを高濃度で含有する飲食品
WO2018117002A1 (ja)	2016-12-21	2018-06-28	サントリーホールディングス株式会社	エピガロカテキンガレート及びシクロプロリルトレオニンを含有する飲食品
KR20220101432A (ko)	2021-01-11	2022-07-19	(주)아모레퍼시픽	갈로카테킨 갈레이트를 함유하는 녹차 추출물을 유효성분으로 포함하는 체지방 감소용 조성물 및 이의 제조방법
KR102690119B1 (ko)	2021-03-22	2024-07-30	카오카부시키가이샤	카테킨류 함유 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS59219384A (ja) *	1983-05-30	1984-12-10	Mitsui Norin Kk	天然抗酸化剤の製造方法
JPS6013780A (ja) *	1983-07-05	1985-01-24	Mitsui Norin Kk	茶カテキン類の製造方法
JPS63214183A (ja) *	1987-03-03	1988-09-06	Mitsui Norin Kk	アンジオテンシン１変換酵素阻害剤
JP2727471B2 (ja) *	1989-09-14	1998-03-11	三井農林株式会社	インフルエンザウィルス感染予防剤

1989
- 1989-10-19 JP JP1270228A patent/JP3018013B2/ja not_active Expired - Lifetime
1990
- 1990-04-12 AU AU53195/90A patent/AU628514B2/en not_active Ceased
- 1990-04-19 EP EP90107475A patent/EP0423419B1/de not_active Expired - Lifetime
- 1990-04-19 CA CA002014971A patent/CA2014971C/en not_active Expired - Fee Related
- 1990-04-19 DE DE69012268T patent/DE69012268T2/de not_active Expired - Fee Related
- 1990-04-19 AT AT90107475T patent/ATE110963T1/de not_active IP Right Cessation
- 1990-04-20 KR KR1019900005521A patent/KR0178522B1/ko not_active Expired - Fee Related

Also Published As

Publication number	Publication date
JP3018013B2 (ja)	2000-03-13
KR0178522B1 (ko)	1999-03-20
JPH03133928A (ja)	1991-06-07
KR910007538A (ko)	1991-05-30
DE69012268T2 (de)	1995-02-23
CA2014971C (en)	1999-12-14
EP0423419A1 (de)	1991-04-24
DE69012268D1 (de)	1994-10-13
AU628514B2 (en)	1992-09-17
CA2014971A1 (en)	1991-04-19
EP0423419B1 (de)	1994-09-07
AU5319590A (en)	1991-04-26

Legal Events

Date	Code	Title	Description
1995-03-15	UEP	Publication of translation of european patent specification
1996-07-15	REN	Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
DE69012268D1 (de)	1994-10-13	Mittel zur Hemmung der alpha-Amylase Aktivität.
EP0417385A3 (en)	1991-04-24	Preventive and curative medicament against infection with influenza virus, containing tea or tea polyphenols
ATE117891T1 (de)	1995-02-15	Zahnbelag verhindernde mittel.
ATE288266T1 (de)	2005-02-15	Zusammensetzung zur behandlung von kondyloma acuminata
DE69622998D1 (de)	2002-09-19	Polyphenol fraktionen von tee, ihre verwendung und diese enthaltende formulierungen
YU75003A (sh)	2006-08-17	Nutriciona farmaceutska formulacija koja uključuje polifenole i upotreba u tretmanu kancera
DE60031921D1 (de)	2007-01-04	Verfahren zu Herstellung von Epigallocatechin Gallate
ES2177506T3 (es)	2002-12-16	Extractos de te verde que contienen catecoles y cafeina.
ES2056094T3 (es)	1994-10-01	Tratamiento y post-tratamiento de metales con compuestos polifenolicos.
KR910015293A (ko)	1991-09-30	항생물질 내성 포도상 구균 감염예방제
ATE125694T1 (de)	1995-08-15	Glukosyltransferase-inhibitoren sowie verfahren zur vorbeugung von karies und anti-karöse nahrungsmittel mittels dieser inhibitoren.
ES457091A1 (es)	1978-08-16	Un procedimiento para producir esteres de catequina o epica-tequina.
EP0400219A3 (de)	1991-01-16	Verwendung von Creosot als antispastischer Wirkstoff
ZA916234B (en)	1993-04-28	New synergistic composition of 2-(2-bromo-2-nitroethenyl)furan and 2-bromo-2-nitropropane-1,3-diol and uses thereof
ATE248571T1 (de)	2003-09-15	Substanz zur behandlung der alopezie
MX2021010491A (es)	2021-10-01	Tratamiento de fibromas con vitamina d y un agente tal como galato de epigalocatequina (egcg).
KR940001884A (ko)	1994-02-16	혈당 상승 억제 방법
JPS53109912A (en)	1978-09-26	Condensed tannin, inactivation of microorganism-originated toxic substance, and attenuation of vaccines using condensed tannin
JPS53141223A (en)	1978-12-08	Preparation of aromatic polyamine